Loading data for ADIL — first visit, this takes a few seconds.

Alerta

ADial Pharmaceuticals Com... (ADIL)

NasdaqCM: ADIL · Precio en tiempo real · USD

4.39

+0.08 (1.86%)

Al cierre: Aug 19, 2026, 8:00 PM

5.76

+0.09%

Fuera de horario: 5:37 PM

1.86% (1D)

No hay datos disponibles

Precio de compra	4.57
Capitalización de mercado	15.11M
Ingresos (TTM)	n/a
Beneficio neto (TTM)	-57.8M
Beta	n/a
EPS (TTM)	-17.71
Ratio PER (TTM)	n/a
Adelante PE	-0.77
P/B (TTM)	-0.39
P/S (TTM)	n/a
Earnings Date	n/a

Precio de venta	3.08
Volumen	51,676
Volumen medio (20D)	458,140
Abierto	4.35
Anterior Cerrar	4.31
Rango del día	4.26 - 4.63
Rango de 52 semanas	1.31 - 10.75
analista	n/a
Precio objetivo	n/a
Dividendos	n/a
Fecha ex dividendo	n/a

Acerca de ADIL

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. The...

[Leer más]

Industria Biotechnology

Sector Healthcare

IPO Fecha Jul 27, 2018

Empleados 5

Bolsa de Valores NasdaqCM

Símbolo bursátil ADIL

Sitio web https://www.adial.com

Perfil completo de la empresa

Desempeño financiero

En 2025, los ingresos de ADial Pharmaceuticals Common Stock fueron 0, un aumento de undefined% en comparación con 0 del año anterior. Las ganancias fueron -7.98M, una disminución de -39.56%.

Estados financieros

Sorpresa de resultados

ADial Pharmaceuticals Common Stock ha publicado sus resultados trimestrales en May 8, 2026:

Ingresos de $0 falla las estimaciones por $0, con NaN% Crecimiento interanual.

EPS de -1.48 supera las estimaciones en 0.77, con 82.59% Crecimiento interanual.

Noticias

2 meses hace · MT Newswires

Sector Update: Healthcare Stocks Higher Late Afternoon

Healthcare stocks rose late Thursday afternoon, with the NYSE Healthcare Index and the State Street

2 meses hace · Stocktwits

ADIL Stock Eyes Best Day In Over 5 Years — Major Pipeline Overhaul And $64M Raise Fuel Rally

Adial on Thursday announced that it has bought privately held Azora Therapeutics.

7 meses hace · Zacks

Has Acurx Pharmaceuticals (ACXP) Outpaced Other Medical Stocks This Year?

Here is how Acurx Pharmaceuticals, Inc. (ACXP) and Adial Pharmaceuticals, Inc. (ADIL) have performed compared to their sector so far this year.

10 meses hace · The Fly

CoreWeave initiated, Instacart downgraded: Wall Street's top analyst calls

11 meses hace · Benzinga

Adial Pharmaceuticals Highlights Favorable Comments From FDA Meeting For Lead Program In Alcohol Use Disorder

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) on Tuesday received the final meeting minutes from its End of Phase 2 (EOP2) Meeting with the U.S. Food and Drug Administration (FDA) held in July. The minute...

Página 1 de 2